Invivyd (IVVD) EBIT (2021 - 2025)

Invivyd (IVVD) has 5 years of EBIT data on file, last reported at -$12.6 million in Q4 2025.

• For the quarter ending Q4 2025, EBIT rose 34.71% year-over-year to -$12.6 million; the trailing twelve-month figure through Dec 2025 stood at -$55.6 million (up 68.59% YoY), and the FY2025 full-year result was -$55.6 million, up 68.59% from the prior year.
• EBIT for Q4 2025 stood at -$12.6 million, down from -$11.0 million in the prior quarter.
• Across five years, EBIT topped out at -$11.0 million in Q3 2025 and bottomed at -$100.7 million in Q1 2022.
• The 5-year median for EBIT is -$46.7 million (2022), against an average of -$46.0 million.
• The widest annual swing landed in 2022, when EBIT slumped 160.25%; it then soared 82.31% in 2025.
• A 5-year view of EBIT shows it stood at -$83.1 million in 2021, then jumped by 41.98% to -$48.2 million in 2022, then slumped by 59.2% to -$76.8 million in 2023, then jumped by 74.95% to -$19.2 million in 2024, then jumped by 34.71% to -$12.6 million in 2025.
• The last three EBIT figures came in at -$12.6 million (Q4 2025), -$11.0 million (Q3 2025), and -$15.1 million (Q2 2025), per Business Quant data.

Peer Comparison